Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Dropout: a simple way to prevent neural networks from overfitting
Monitoring Required: Observe patients for any side effects, particularly if receiving high doses or prolonged treatment
Approximately 20%-30% of individuals with MASLD progress to MASH, characterized by hepatocyte ballooning, lobular inflammation, and variable fibrosis, and 10%-20% of MASH patients develop advanced fibrosis (stages F3-F4) or cirrhosis over their lifetime [6,13]
Knowing what to verify before you enroll is the difference between a well-informed subscription decision and one made without the relevant context
US$ 21.31
US$ 21.29
US$ 24.81
US$ 28.24
US$ 28.62
US$ 21.58
US$ 20.04
US$ 23.29
US$ 22.94
US$ 29.30
US$ 27.58
